Eli Lilly, Verve Therapeutics to file US antitrust paperwork today
Eli Lilly and Verve Therapeutics expect to file the notification of their $1 billion deal with US antitrust authorities today, Verve said in a filing with the US Securities and Exchange...To view the full article, register now.
Already a subscriber? Click here to view full article